Rigel Reports Second Quarter 2020 Financial Results, Provides Business Update, and Overviews COVID-19 Program Aug 04, 2020 4:01pm EDT
Rigel Announces Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Business Update Jul 28, 2020 7:30am EDT
Rigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology Jul 27, 2020 7:30am EDT
Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia Jul 14, 2020 7:30am EDT
Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe Jul 09, 2020 8:19am EDT
Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference Jun 17, 2020 7:30am EDT
Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress Jun 11, 2020 7:30am EDT
Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress Jun 03, 2020 7:30am EDT
